KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Aug 19, 2019 $22.67 $22.88 $21.13 $21.40 1 065 131
Aug 16, 2019 $21.89 $22.47 $21.81 $22.43 742 038
Aug 15, 2019 $21.25 $22.00 $21.24 $21.79 798 154
Aug 14, 2019 $21.11 $21.61 $20.93 $21.15 736 496
Aug 13, 2019 $20.12 $21.67 $20.12 $21.56 1 016 823
Aug 12, 2019 $19.02 $20.35 $19.00 $20.13 614 327
Aug 09, 2019 $18.86 $19.55 $18.72 $19.26 742 546
Aug 08, 2019 $19.16 $19.47 $18.99 $19.34 473 469
Aug 07, 2019 $19.25 $19.44 $18.96 $19.10 765 452
Aug 06, 2019 $18.85 $19.60 $18.57 $19.50 653 113
Aug 05, 2019 $18.81 $18.81 $18.39 $18.73 563 049
Aug 02, 2019 $19.27 $19.88 $18.80 $18.97 427 381
Aug 01, 2019 $19.25 $19.66 $18.80 $19.45 447 218
Jul 31, 2019 $19.92 $20.11 $19.11 $19.25 685 833
Jul 30, 2019 $18.81 $19.81 $18.78 $19.78 513 140
Jul 29, 2019 $18.78 $18.97 $18.51 $18.91 293 949
Jul 26, 2019 $18.57 $18.86 $18.57 $18.79 385 232
Jul 25, 2019 $18.76 $18.79 $18.51 $18.51 565 204
Jul 24, 2019 $18.68 $19.00 $18.44 $18.89 335 573
Jul 23, 2019 $18.50 $18.83 $18.38 $18.77 240 069
Jul 22, 2019 $18.34 $18.59 $18.06 $18.55 342 353
Jul 19, 2019 $18.04 $18.51 $17.86 $18.34 493 691
Jul 18, 2019 $18.94 $19.06 $18.02 $18.09 809 045
Jul 17, 2019 $18.78 $19.04 $18.59 $18.99 578 578
Jul 16, 2019 $18.98 $19.14 $18.52 $18.78 496 044
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT